Biolinq develops Biolinq Shine™, a fully autonomous, needle-free glucose sensor designed to simplify continuous glucose monitoring. The company focuses on non-invasive biosensing that integrates glucose, activity, and sleep information in a single wearable device to support healthier, data-driven decisions.

Biolinq's technology uses a first-of-its-kind LED-based glucose range monitoring system that provides real-time visual feedback (for example, a blue LED indicates target glucose range) and delivers actionable insights even without a phone. The platform aims to make continuous biosensing simple, accessible, and user-friendly.

Biolinq aims to bring biosensing and biowearables mainstream over the next decade. The company emphasizes culture and shared values in hiring and seeks talent motivated by improving health outcomes for millions of people. Note: Biolinq Shine is an investigational device limited by federal law to investigational use.